Search Results 1941-1950 of 16591 for Maximum

  1. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  2. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    * Previously treated with maximum feasible resection or biopsy, radiation, and temozolomide * Have an enhancing mass on magnetic resonance imaging (MRI) ...

  3. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - Mayo Clinic

    - Age: Maximum serum creatinine (mg/dL); - 3 to < 6 years: 0.8 (male), 0.8 (female); - 6 to < 10 years: 1 (male), 1 (female); - 10 to < 13 years: 1.2 (male) ...

  4. Neurology - Clinical trials - Mayo Clinic

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  5. Gastroenterology and Hepatology - Clinical trials

    Difference in gastric emptying (T1/2, emptying at 2h and emptying at 4h);; Volume to fullness (sensation of usual postprandial fullness) and maximum feeling of ...

  6. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

    Part A (dose regimen finding) will involve dose escalation and possible dose interval modification to define the maximum tolerated dose (MTD) and/or ...

  7. A Study to Analyze NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma - Mayo Clinic

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  8. Neurology - Clinical trials

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  9. Oncology (Medical) - Clinical trials

    ... maximum) over a period of 12 months * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 ...

  10. Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) (INFUSE) - Mayo Clinic

    Patients not on the transplant waitlist or transplant eligible are also eligible for the trial (maximum 25 subjects). Exclusion Criteria: Serum creatinine ...